Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.
2.

A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study.

Bowering K, Reed VA, Felicio JS, Landry J, Ji L, Oliveira J.

Diabet Med. 2012 Sep;29(9):e263-72. doi: 10.1111/j.1464-5491.2012.03722.x. Erratum in: Diabet Med. 2012 Nov;29(11):1473. Felicio, J [corrected to Felicio, J S].

PMID:
22672081
3.

[Oral treatment of type 2 diabetes mellitus].

Palitzsch KD.

Dtsch Med Wochenschr. 2012 Sep;137(38):1859-68, quiz 1869-72. doi: 10.1055/s-0032-1305191. Epub 2012 Sep 12. Review. German. No abstract available.

PMID:
22971973
4.

Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trial.

Koivisto V, Cleall S, Pontiroli AE, Giugliano D.

Diabetes Obes Metab. 2011 Dec;13(12):1149-57. doi: 10.1111/j.1463-1326.2011.01484.x.

PMID:
21819517
5.

Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

Ann Intern Med. 2008 Oct 21;149(8):531-9.

PMID:
18936501
6.

Effects on post-prandial glucose and AGE precursors from two initial insulin strategies in patients with type 2 diabetes uncontrolled by oral agents.

Sakharova OV, Lleva RR, Dziura JD, Spollett GR, Howell SK, Beisswenger PJ, Inzucchi SE.

J Diabetes Complications. 2012 Jul-Aug;26(4):333-8. doi: 10.1016/j.jdiacomp.2012.03.027. Epub 2012 Apr 26.

PMID:
22541894
7.

Potential for use of 1,5-anhydroglucitol when initiating insulin therapy in people with type 2 diabetes and suboptimal control with oral antidiabetic drugs.

Dungan KM, Buse JB, Herman WH, Arakaki RF, Jiang HH, Jacobson JG, Fahrbach JL.

Diabetes Res Clin Pract. 2012 Jun;96(3):e66-9. doi: 10.1016/j.diabres.2012.02.005. Epub 2012 Mar 14.

PMID:
22421598
8.

Summaries for patients. Comparison of two types of insulin added to diabetes pills in poorly controlled type 2 diabetes.

[No authors listed]

Ann Intern Med. 2008 Oct 21;149(8):I-46. No abstract available.

PMID:
18936498
9.
11.

Efficacy and safety of prandial premixed therapy using insulin lispro mix 50/50 3 times daily compared with progressive titration of insulin lispro mix 75/25 or biphasic insulin aspart 70/30 twice daily in patients with type 2 diabetes mellitus: a randomized, 16-week, open-label study.

Farcasiu E, Ivanyi T, Mozejko-Pastewka B, Birkus Z, Csog J, Kowalska I, Coetzer TF, Bulgurlu S, Schinzel B, Kiljanski J.

Clin Ther. 2011 Nov;33(11):1682-93. doi: 10.1016/j.clinthera.2011.10.001. Epub 2011 Oct 27.

PMID:
22036246
12.

Course of glycaemia in poorly controlled type 2 diabetes patients 2.5 years after optimizing oral treatment in general practice.

Berghout LM, Gorter KJ, Rutten GE.

Eur J Gen Pract. 2006;12(2):80-2. No abstract available.

PMID:
16945883
14.

Effects of insulin glulisine as mono- or add-on therapy in patients with type 2 diabetes mellitus.

Kawamori R, Iwamoto Y, Kadowaki T, Iwasaki M, Kim SW, Woo JT, Baik SH, Yoon KH.

Diabetes Obes Metab. 2009 Sep;11(9):900-9. doi: 10.1111/j.1463-1326.2009.01088.x. Epub 2009 Jul 13.

PMID:
19614946
15.

Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia).

Seino Y, Min KW, Niemoeller E, Takami A; EFC10887 GETGOAL-L Asia Study Investigators.

Diabetes Obes Metab. 2012 Oct;14(10):910-7. doi: 10.1111/j.1463-1326.2012.01618.x. Epub 2012 May 30.

16.

Combined insulin and sulfonylurea therapy for type 2 diabetes mellitus.

Riddle MC.

Diabetes Res Clin Pract. 1991 Jan;11(1):3-8. Review. No abstract available.

PMID:
2019232
17.
18.

Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes.

Malone JK, Bai S, Campaigne BN, Reviriego J, Augendre-Ferrante B.

Diabet Med. 2005 Apr;22(4):374-81.

PMID:
15787659
19.

[Hypoglycemia: danger to life of diabetic patients. Higher price for blood sugar adjustment].

Füessl HS.

MMW Fortschr Med. 2005 Aug 4;147(31-32):4-6, 8. German. No abstract available.

PMID:
16128187
20.

[Combination therapy of insulin sensitizer, thiazolidinedione drugs, and sulfonylurea].

Ohmura E, Hosaka D, Imai Y, Kawazu S.

Nihon Rinsho. 2002 Sep;60 Suppl 9:470-5. Review. Japanese. No abstract available.

PMID:
12387036
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk